Connecticut 2017 Regular Session

Connecticut Senate Bill SB00435 Latest Draft

Bill / Introduced Version Filed 01/18/2017

                            General Assembly  Proposed Bill No. 435
January Session, 2017  LCO No. 3113
 *03113*
Referred to Committee on PUBLIC HEALTH
Introduced by:
SEN. SLOSSBERG, 14th Dist.

General Assembly

Proposed Bill No. 435 

January Session, 2017

LCO No. 3113

*03113*

Referred to Committee on PUBLIC HEALTH 

Introduced by:

SEN. SLOSSBERG, 14th Dist.

AN ACT PROVIDING ACCESS TO PRESCRIPTION BRANDS THAT ARE MEDICALLY NECESSARY FOR PEOPLE DIAGNOSED WITH EPILEPSY.

Be it enacted by the Senate and House of Representatives in General Assembly convened:

That the general statutes be amended to provide access to prescription brands that are medically necessary for the treatment of persons diagnosed with epilepsy.

Statement of Purpose: 

To provide access to prescription drug brands that are medically necessary for the treatment of persons diagnosed with epilepsy.